Back
Adverum Biotechnologies Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
29
ADVM
Adverum Biotechnologies
Last Price:
$4.73
Seasonality Move:
20.2%
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.12
Seasonality Move:
7.64%
Sell
29
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
-
The current Adverum Biotechnologies [ADVM] share price is $4.74. The Score for ADVM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ADVM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $4.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing slight selling pressure.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $7.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.
ADVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 26.02 | Sell |
Chaikin Money Flow: | -19445 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.3 - 6.52) | Sell |
Bollinger Bands (100): | (6.15 - 7.75) | Sell |
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 34.11 | Sell |
Chaikin Money Flow: | -639404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.76 - 9.04) | Sell |
Bollinger Bands (100): | (7.84 - 10.36) | Sell |
ADVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.22 | Sell |
20-day SMA: | 5.79 | Sell |
50-day SMA: | 6.88 | Sell |
200-day SMA: | 8.49 | Sell |
8-day EMA: | 5.14 | Sell |
20-day EMA: | 5.71 | Sell |
50-day EMA: | 6.43 | Sell |
200-day EMA: | 8.25 | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.62 | Sell |
20-day SMA: | 8.29 | Sell |
50-day SMA: | 9.7 | Sell |
200-day SMA: | 11.63 | Sell |
8-day EMA: | 7.61 | Sell |
20-day EMA: | 8.25 | Sell |
50-day EMA: | 8.98 | Sell |
200-day EMA: | 10.9 | Sell |
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.70 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Adverum Biotechnologies Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
EyePoint Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |